The room, in its own words. Recorded on the floor at the Bio Innovation Leaders Summit, not written afterwards.
We have seen so much benefit for so many patients in hematologic cancers. But with the current generation, the supply is limited. I want this industry to innovate and create new ways to make these products accessible to patients on a global scale.
Jens H. Vogel
SVP & Head of Global Biologics Operating Unit · MSD
I was ambitious. I wanted to be an oncologist, to save patients. Being in that role, I realised how helpless I was. Even as a physician, I could not help those patients when they faced death.
Judy Chou
President and CEO · AltruBio
Watching loved ones get seriously ill, or live with chronic disease, is the biggest motivator for bringing innovation into medical research and development.
Angela Vollstedt, PhD MBA
Director Global Cell & Gene Therapies Portfolio Management · Novartis
Ten years after therapy and they are still cancer free. That is what we need to work on now. To bring these therapies to patients globally.
Nuno Fontes
SVP Head of Global CMC · WuXi Biologics
I would give it a nine. Only because I am German, and usually I do not give a ten. But it is pretty darn close.
Jens H. Vogel · MSD · on BILS
request accessA note on privacy.
This site uses essential cookies to function. We optionally use analytics to understand how the site is used. Nothing is shared. Nothing is sold.